The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictive markers of complete pathological response to neoadjuvant chemo-immunotherapy in triple negative breast cancer.
 
Kaja Cankar
Honoraria - Lilly; Novartis
Travel, Accommodations, Expenses - Lilly; MSD Oncology
 
Maša Auprih
No Relationships to Disclose
 
Tanja Ovcaricek
Employment - Krka (I)
Stock and Other Ownership Interests - Krka
Honoraria - Astellas Amgen BioPharama; AstraZeneca; Bayer; Bayer; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Novartis; Roche
Travel, Accommodations, Expenses - Astellas Oncology; Roche
 
Anja Kovac
Honoraria - Amgen; AstraZeneca; Ewopharma; MSD; Novartis
Consulting or Advisory Role - Amgen; MSD
Travel, Accommodations, Expenses - MSD; Pfizer
 
Natasa Snoj Sarvari
No Relationships to Disclose
 
Luka Dobovisek
Stock and Other Ownership Interests - Krka
Honoraria - Novartis; Pfizer; Roche
Consulting or Advisory Role - Novartis
 
Simona Borstnar
Honoraria - AstraZeneca; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Roche; Sandoz
Consulting or Advisory Role - AstraZeneca; Lilly; MSD Oncology; Novartis; Pfizer; Roche